Brokerages Set Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Target Price at $74.92
Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been given an average rating of “Buy” by the thirteen ratings firms that are currently covering the firm, Marketbeat Ratings reports. Thirteen research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have covered the stock […]
Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been given an average rating of “Buy” by the thirteen ratings firms that are currently covering the firm, Marketbeat Ratings reports. Thirteen research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have covered the stock […]
